|
RBM8A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64135371960583E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.01267949160456E-12 |
| Normal-vs-Stage2 |
1.40819999994157E-07 |
| Normal-vs-Stage3 |
1.53654866608122E-13 |
| Normal-vs-Stage4 |
4.89697171701664E-12 |
| Stage1-vs-Stage2 |
8.945400E-01 |
| Stage1-vs-Stage3 |
1.914020E-01 |
| Stage1-vs-Stage4 |
9.287600E-02 |
| Stage2-vs-Stage3 |
2.946000E-01 |
| Stage2-vs-Stage4 |
1.376980E-01 |
| Stage3-vs-Stage4 |
4.818200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.24344978758018E-14 |
| Normal-vs-AfricanAmerican |
7.832400E-04 |
| Normal-vs-Asian |
1.55789999789491E-08 |
| Caucasian-vs-AfricanAmerican |
8.231800E-02 |
| Caucasian-vs-Asian |
7.671000E-01 |
| AfricanAmerican-vs-Asian |
1.906050E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.88578058618805E-15 |
| Normal-vs-Female |
3.56847884575018E-12 |
| Male-vs-Female |
4.515900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.70810074154815E-11 |
| Normal-vs-Age(41-60Yrs) |
3.92774701651888E-12 |
| Normal-vs-Age(61-80Yrs) |
2.17204032537666E-12 |
| Normal-vs-Age(81-100Yrs) |
1.157460E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.380200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.398830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.977400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.212800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.069000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.585600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.194400E-04 |
| Classical-VS-Follicular |
1.175090E-03 |
| Classical-VS-Other |
6.171700E-02 |
| Classical-VS-Normal |
4.46810366483419E-11 |
| Tall-VS-Follicular |
7.492000E-01 |
| Tall-VS-Other |
6.180400E-01 |
| Tall-VS-Normal |
7.79598607891785E-13 |
| Follicular-VS-Other |
5.256000E-01 |
| Follicular-VS-Normal |
6.59550192239067E-12 |
| Other-VS-Normal |
4.2113999999982E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.3884674500182E-12 |
| Normal-vs-N1 |
4.97160090873194E-11 |
| N0-vs-N1 |
2.328000E-01 |
|
|
